Antidepressant action of HDAC inhibition in the prefrontal cortex

Neuroscience

Volumn 298, Issue , 2015, Pages 329-335

  Covington, H E ^a   Maze, I ^a   Vialou, V ^a,b   Nestler, E J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Depression; Gene expression; HDAC inhibitors; MS 275

Indexed keywords

ENTINOSTAT; FLUOXETINE; HISTONE DEACETYLASE; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; HISTONE DEACETYLASE 3; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; ENZYME INHIBITION; ENZYME REGULATION; FORCED SWIM TEST; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; SOCIAL INTERACTION; SOCIAL STRESS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; ENZYMOLOGY; HYPODERMOCLYSIS; MENTAL STRESS; METABOLISM; PATHOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTINEOPLASTIC AGENTS; BENZAMIDES; DISEASE MODELS, ANIMAL; FLUOXETINE; HISTONE DEACETYLASES; HYPODERMOCLYSIS; MALE; MICE; MICE, INBRED C57BL; PREFRONTAL CORTEX; PYRIDINES; STRESS, PSYCHOLOGICAL;

EID: 84928735279     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.04.030     Document Type: Article

References (30)

1. Abel T., Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008, 8:57-64.
2. Bagot R.C., Labonte B., Peña C.J., Nestler E.J. Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues Clin Neurosci 2014, 16:281-295.
3. Berton O., McClung C.A., DiLeone R.J., Krishnan V., Russo S., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
4. Borrelli E., Nestler E.J., Allis C.D., Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60:961-974.
5. Carlezon W.A., Duman R.S., Nestler E.J. The many faces of CREB. Trends Neurosci 2005, 28:436-445.
6. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Yoshinori O.N., Berton O., Fass D.M., Renthal W., Rush A.J., Wu E.Y., Ghose S., Krishnan V., Russo S.J., Tamminga C., Haggarty S.J., Nestler E.J. Antidepressant actions of HDAC inhibitors. J Neurosci 2009, 29:11451-11460.
7. Covington H.E., Vialou V.F., Laplant Q., Ohnishi Y.N., Nestler E.J. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci Lett 2011, 493:122-126.
8. Duman R.S. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci 2014, 16:11-27.
9. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
10. Fraczek J., Vanhaecke T., Rogiers V. Toxicological and metabolic considerations for histone deacetylase inhibitors. Expert Opin Drug Metab Toxicol 2013, 9:441-457.
11. Graff J., Tsai L.H. Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 2013, 14:97-111.
12. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10:32-42.
13. Hinwood M., Tynan R.J., Day T.A., Walker F.R. Repeated social defeat selectively increases δFosB expression and histone H3 acetylation in the infralimbic medial prefrontal cortex. Cereb Cortex 2011, 21:262-271.
14. Hollis F., Wang H., Dietz D., Gunjan A., Kabbaj M. The effects of repeated social defeat on long-term depressive-like behavior and short-term histone modifications in the hippocampus in male Sprague-Dawley rats. Psychopharmacology 2010, 211:69-77.
15. Hollis F., Duclot F., Gunjan A., Kabbaj M. Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus. Horm Behav 2011, 59:331-337.
16. Hooker J.M., Kim S.W., Alexoff D., Xu Y., Shea C., Reid A., Volkow N., Fowler J.S. Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using Positron Emission Tomography. ACS Chem Neurosci 2010, 1:65-73.
17. Kennedy P.J., Feng J., Robison A.J., Maze I., Badimon A., Mouzon E., Chaudhury D., Damez-Werno D.M., Haggarty S.J., Han M.H., Bassel-Duby R., Olson E.N., Nestler E.J. Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation. Nat Neurosci 2013, 16:434-440.
18. Kenworthy C.A., Sengupta A., Luz S.M., Ver Hoeve E.S., Meda K., Bhatnagar S., Abel T. Social defeat induces changes in histone acetylation and expression of histone modifying enzymes in the ventral hippocampus, prefrontal cortex, and dorsal raphe nucleus. Neuroscience 2013, 264:88-98.
19. Khan N., Jeffers M., Kumar S., Hackett C., Boldog F., Khramtsov N., Qian X., Mills E., Berghs S.C., Carey N., Finn P.W., Collins L.S., Tumber A., Ritchie J.W., Jensen P.B., Lichenstein H.S., Sehested M. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 2009, 409:581-589.
20. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
21. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nat Rev Neurosci 2013, 14:609-625.
22. Schroeder F.A., Lin C.L., Crusio W.E., Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007, 62:55-64.
23. Smart O.L., Tiruvadi V.R., Mayberg H.S. multimodal approaches to define network oscillations in depression. Biol Psychiatry 2015, in press, PMID:25681871.
24. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
25. Sun H.S., Kennedy P.J., Nestler E.J. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacol Rev 2013, 38:124-137.
26. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in hippocampus in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
27. Vialou V., Robison A.J., Laplant Q.C., Covington H.E., Dietz D.M., Ohnishi Y.N., Mouzon E., Rush A.J., Watts E.L., Wallace D.L., Iñiguez S.D., Ohnishi Y.H., Steiner M.A., Warren B.L., Krishnan V., Bolaños C.A., Neve R.L., Ghose S., Berton O., Tamminga C.A., Nestler E.J. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010, 13:745-752.
28. Vialou V., Feng J., Robison A.J., Nestler E.J. Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 2013, 53:59-87.
29. Vialou V., Bagot R.C., Cahill M.E., Ferguson D., Robison A.J., Dietz D.M., Fallon B., Mazei-Robison M., Ku S.M., Harrigan E., Winstanley C.A., Joshi T., Feng J., Berton O., Nestler E.J. Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of δFosB. J Neurosci 2014, 34:3878-3887.
30. Zhu H., Huang Q., Xu H., Niu L., Zhou J.N. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors. Behav Brain Res 2009, 196:200-206.